Sibel Ertek

1.3k total citations
38 papers, 943 citations indexed

About

Sibel Ertek is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sibel Ertek has authored 38 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sibel Ertek's work include Blood Pressure and Hypertension Studies (4 papers), Thyroid Disorders and Treatments (4 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Sibel Ertek is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Thyroid Disorders and Treatments (4 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Sibel Ertek collaborates with scholars based in Türkiye, Italy and United States. Sibel Ertek's co-authors include Arrigo F.G. Cicero, Claudio Borghi, Gürbüz Erdoğan, Şevki Çetinkalp, Mustafa Cesur, Meral Gülhan, Şengül Çehreli, Kaspar Berneis, Cumali Efe and Manfredi Rizzo and has published in prestigious journals such as Atherosclerosis, European Journal of Public Health and Expert Opinion on Biological Therapy.

In The Last Decade

Sibel Ertek

38 papers receiving 911 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sibel Ertek Türkiye 16 264 184 159 151 139 38 943
Elisa Grandi Italy 17 201 0.8× 232 1.3× 180 1.1× 119 0.8× 207 1.5× 62 1.1k
Midori Yatabe Japan 16 264 1.0× 137 0.7× 183 1.2× 99 0.7× 257 1.8× 43 863
Melahat Dirican Türkiye 18 210 0.8× 104 0.6× 140 0.9× 113 0.7× 90 0.6× 53 958
Mahdi Garelnabi United States 18 141 0.5× 231 1.3× 234 1.5× 134 0.9× 148 1.1× 46 1.2k
Nataša Bogavac‐Stanojević Serbia 18 221 0.8× 280 1.5× 202 1.3× 132 0.9× 228 1.6× 107 1.3k
Maddalena Veronesi Italy 19 256 1.0× 187 1.0× 146 0.9× 98 0.6× 306 2.2× 46 931
Eduardo Meaney Mexico 18 266 1.0× 173 0.9× 274 1.7× 226 1.5× 341 2.5× 80 1.2k
David C. Lieb United States 12 162 0.6× 154 0.8× 174 1.1× 131 0.9× 154 1.1× 31 756
PP Nawroth Germany 15 378 1.4× 167 0.9× 279 1.8× 344 2.3× 116 0.8× 44 1.3k
George-Angelo Papamikroulis Greece 9 268 1.0× 151 0.8× 270 1.7× 172 1.1× 205 1.5× 24 1.1k

Countries citing papers authored by Sibel Ertek

Since Specialization
Citations

This map shows the geographic impact of Sibel Ertek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibel Ertek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibel Ertek more than expected).

Fields of papers citing papers by Sibel Ertek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sibel Ertek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibel Ertek. The network helps show where Sibel Ertek may publish in the future.

Co-authorship network of co-authors of Sibel Ertek

This figure shows the co-authorship network connecting the top 25 collaborators of Sibel Ertek. A scholar is included among the top collaborators of Sibel Ertek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sibel Ertek. Sibel Ertek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ertek, Sibel & Kayser Çağlar. (2025). Underestimated reason of hyperkalemia in diabetic patients: type IV renal tubular acidosis- mini review. Frontiers in Clinical Diabetes and Healthcare. 6. 1570868–1570868. 1 indexed citations
2.
Erdoğan, Murat Faik, Özgür Demir, Reyhan Ersoy, et al.. (2016). Comparison of Early Total Thyroidectomy with Antithyroid Treatment in Patients with Moderate-Severe Graves' Orbitopathy: A Randomized Prospective Trial. European Thyroid Journal. 5(2). 106–111. 9 indexed citations
3.
Cicero, Arrigo F.G., et al.. (2014). Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data. Expert Opinion on Drug Safety. 13(8). 1023–1030. 31 indexed citations
4.
Cicero, Arrigo F.G., et al.. (2014). Nutraceuticals for Metabolic Syndrome Management: From Laboratory to Benchside. Current Vascular Pharmacology. 12(4). 565–571. 30 indexed citations
5.
Cicero, Arrigo F.G., et al.. (2014). Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence. Expert Opinion on Biological Therapy. 14(6). 863–868. 18 indexed citations
6.
Çetinkalp, Şevki, et al.. (2014). Insulin Resistance in Brain and Possible Therapeutic Approaches. Current Vascular Pharmacology. 12(4). 553–564. 44 indexed citations
7.
Ertek, Sibel & Arrigo F.G. Cicero. (2013). State of the art paper Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology. Archives of Medical Science. 5(5). 944–952. 86 indexed citations
8.
9.
Ertek, Sibel, Reyhan Ersoy, Cüneyd Anıl, et al.. (2012). Hypothyroidism, new nodule formation and increase in nodule size in patients who have undergone hemithyroidectomy. Archives of Medical Science. 2(2). 263–269. 4 indexed citations
10.
11.
Ertek, Sibel, Arrigo F.G. Cicero, & Gürbüz Erdoğan. (2011). The relationship between calcium metabolism, insulin-like growth factor-1 and pulse pressure in normotensive, normolipidaemic and non-diabetic patients. Archives of Medical Science. 5(5). 776–780. 3 indexed citations
12.
Ertek, Sibel. (2011). Endokrinolojide Tele-Sağlık ve Tele-Tıp Uygulamaları. DergiPark (Istanbul University). 126–130. 6 indexed citations
13.
Ertek, Sibel & Gürbüz Erdoğan. (2010). Postpartum thyroiditis and hypothalamo-hypophysial insufficiency in the same woman with successive pregnancies: a case report. Gynecological Endocrinology. 26(2). 105–108. 4 indexed citations
14.
Özbalkan, Zeynep, Cumali Efe, Mustafa Cesur, et al.. (2010). An update on the relationships between rheumatoid arthritis and atherosclerosis. Atherosclerosis. 212(2). 377–382. 46 indexed citations
15.
Cicero, Arrigo F.G. & Sibel Ertek. (2010). Preclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans. Archives of Medical Science. 4(4). 469–477. 10 indexed citations
16.
17.
Ertek, Sibel, et al.. (2010). Relationship between serum zinc levels, thyroid hormones and thyroid volume following successful iodine supplementation. HORMONES. 9(3). 263–268. 51 indexed citations
18.
Cicero, Arrigo F.G., Sibel Ertek, & Claudio Borghi. (2009). Omega-3 Polyunsaturated Fatty Acids: Their Potential Role in Blood Pressure Prevention and Management. Current Vascular Pharmacology. 7(3). 330–337. 87 indexed citations
19.
20.
Ertek, Sibel, Mutlu Arat, İrfan Soykan, et al.. (2005). Fatal fulminant hepatic failure during treatment of multiple myeloma. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 58(3). 146–148. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Grandi Breakdown of academic impact, for papers by Midori Yatabe Breakdown of academic impact, for papers by Melahat Dirican Breakdown of academic impact, for papers by Mahdi Garelnabi Breakdown of academic impact, for papers by Nataša Bogavac‐Stanojević Breakdown of academic impact, for papers by Maddalena Veronesi Breakdown of academic impact, for papers by Eduardo Meaney Breakdown of academic impact, for papers by David C. Lieb Breakdown of academic impact, for papers by PP Nawroth Breakdown of academic impact, for papers by George-Angelo Papamikroulis
Rankless by CCL
2026